Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
2 registered trials, newest registry update first. Showing only trials linked to Petrelintide.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) NCT06926842 | Petrelintide | Phase 2 | Completed | Zealand Pharma | 221 | Aug 13, 2026 | Sep 9, 2026 |
| Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities NCT06662539 | Petrelintide | Phase 2 | Completed | Zealand Pharma | 493 | Sep 30, 2025 | Mar 23, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.